Accuray Inc (ARAY) stock
ARAYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
$2.80−0.28 (-9.09%)
Close on Nov 13, 2026Market cap $334.43MP/E –Yield –
Accuray r&d expenses
Research and development expenses are spending on new products and technology.
Accuray's R&D Expenses for the twelve months ending Sep 30, 2026 was $34.35M, down 27.0% year over year. For fiscal 2026 it was $37.75M, down 21.3% from the year before. Over ten years it grew -4.0% a year on average. The highest annual figure on record is $81.29M in fiscal 2012.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $37.75M | -21.3% |
| FY2025 | Jun 30, 2025 | $47.94M | -3.6% |
| FY2024 | Jun 30, 2024 | $49.73M | -12.9% |
| FY2023 | Jun 30, 2023 | $57.13M | -1.1% |
| FY2022 | Jun 30, 2022 | $57.75M | +9.5% |
| FY2021 | Jun 30, 2021 | $52.73M | +5.9% |
| FY2020 | Jun 30, 2020 | $49.78M | -11.9% |
| FY2019 | Jun 30, 2019 | $56.49M | -1.3% |
| FY2018 | Jun 30, 2018 | $57.25M | +14.7% |
| FY2017 | Jun 30, 2017 | $49.92M | -11.9% |
| FY2016 | Jun 30, 2016 | $56.65M | +1.6% |
| FY2015 | Jun 30, 2015 | $55.75M | +3.8% |
| FY2014 | Jun 30, 2014 | $53.72M | -18.8% |
| FY2013 | Jun 30, 2013 | $66.20M | -18.6% |
| FY2012 | Jun 30, 2012 | $81.29M | +96.8% |
| FY2011 | Jun 30, 2011 | $41.30M | +31.0% |
| FY2010 | Jun 30, 2010 | $31.52M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $7.81M | -30.4% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $7.71M | -32.8% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $8.18M | -23.7% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $10.65M | -21.9% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $11.22M | -7.4% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $11.47M | +20.4% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $10.71M | -1.8% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $13.64M | -10.7% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $12.12M | -13.5% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $9.53M | -32.8% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $10.91M | -23.2% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $15.28M | +4.4% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $14.01M | -0.6% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $14.19M | -2.6% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $14.21M | +0.7% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $14.64M | -0.4% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $14.09M | -2.0% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $14.57M | -5.1% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $14.10M | +6.3% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $14.70M | +22.9% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $14.38M | +18.4% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $15.36M | +25.7% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $13.27M | +18.8% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $11.96M | -8.5% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $12.15M | -8.9% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $12.22M | -23.9% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $11.16M | -13.5% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $13.06M | -4.2% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $13.34M | -3.9% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $16.05M | +10.0% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $12.91M | -8.4% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $13.64M | +2.8% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $13.89M | +11.3% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $14.59M | +22.1% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $14.09M | +15.2% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $13.26M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $12.48M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $11.94M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $12.23M | – |
See a number that looks wrong?